Unitedhealth Group is a healthcare plan company located in Minnesota, United States, which is part of the Healthcare sector, and is traded under the ticker UNH on the NYSE exchange.
Unitedhealth Group stock last closed at $299.84, down 1.45% from the previous day, and has decreased 48.36% in one year. It has underperformed other stocks in the Healthcare Plans industry by 0.13 percentage points. Unitedhealth Group stock is currently +27.81% from its 52-week low of $234.60, and -52.46% from its 52-week high of $630.73.
There are currently 905.67M shares of UNH outstanding. The market cap of UNH is $271.56B. In the past 24 hours, 16.63M UNH shares were traded.
You need an online brokerage account to access the NYSE market and buy UNH shares.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal info so you are able to invest in UNH stock today.
Now that you've filled out your info on the best stock buying app, your next step is to transfer the money for your investment:
Watch the video below to see the process of transferring money into your brokerage account.
After you have figured out the best place to buy Unitedhealth Group stock, it's absolutely critical to research their stock prior to buying, so you can understand the risk and opportunity.
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on UNH's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge UNH's true value.
Using relative valuations ratios:
You can access additional valuation research on UNH's stock here.
Out of 19 Wall Street analysts who research UNH, the consensus analyst rating on Unitedhealth Group is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Michael Ha, a bottom 6% analyst from Baird downgrades UNH to a sell rating and lowers their UNH price target from $312.00 to $198.00, on Jul 31, 2025.
Baird's Michael Ha downgraded their rating on Unitedhealth Group (NYSE: UNH) from Hold to Sell on 2025/07/31. The analyst also lowered their price target by 36.5% from $312 to $198.
UnitedHealth Group reported its Q2 2025 earnings.
Ha downgraded the stock and cut their price target in response because, they said, the company's road ahead is more challenging following the print.
The analyst said they do not believe UnitedHealth Group will be able to maintain 1% OptumHealth value-based care margins in 2026.
Further, Ha said, the company's other segments now appear more challenged than expected.
Even in an optimistic earnings growth scenario, the stock's current price "does not appear overly inexpensive," the analyst cautioned.
For Q2 2025, UnitedHealth Group reported:
For FY 2025, management guided:
CEO Stephen Hemsley commented: “UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly.
“As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values."
Ben Hendrix, a top 22% analyst from RBC Capital maintains UNH with a buy rating and lowers their UNH price target from $355.00 to $286.00, on Jul 30, 2025.
Michael Wiederhorn, a bottom 8% analyst from Oppenheimer maintains UNH with a buy rating and lowers their UNH price target from $400.00 to $325.00, on Jul 30, 2025.
Matthew Gillmor, a top 10% analyst from KeyBanc maintains UNH with a strong buy rating and lowers their UNH price target from $400.00 to $350.00, on Jul 30, 2025.
Jessica Tassan, a bottom 16% analyst from Piper Sandler maintains UNH with a strong buy rating and lowers their UNH price target from $353.00 to $317.00, on Jul 30, 2025.
You can dive deeper into what analysts are saying on the Unitedhealth Group stock forecast page.
Last year, UNH earnings were $21.30B. Over the last five year, UNH's earnings have gone up by 5.24% per year. This was faster than the Healthcare Plans industry average of 1.12%.
Last year, UNH revenue was $422.82B. In the last five year, UNH's revenue has grown by 11.28% per year. This was slower than the Healthcare Plans industry average of 11.49%.
You can research UNH's earnings and revenue performance here.
In the past 12 months, insiders at UNH have bought more shares than they have sold.
Patrick Hugh Conway, Chief Executive Officer Optum of UNH, was the latest UNH insider to sell. They sold $179,645.00 worth of UNH shares on Jun 10, 2025.
Learn more about who owns UNH shares here.
Unitedhealth Group pays a dividend of 2.84%, compared to the Healthcare Plans industry's average dividend yield of 1.84%. If you owned $1,000 worth of UNH stock, you would have received $28.38 in the past 12 months.
Unitedhealth Group dividend payments have consistently grown over the past decade and have remained stable.
Find more info about Unitedhealth Group dividend yield and history here.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main options:
Click the Open button and eToro will place your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Now that you own some shares in UNH, you'll want to keep up with your new company.
Create a watchlist to keep tabs on your UNH stock.
To reiterate, here are the 6 steps to buy Unitedhealth Group stock:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Unitedhealth Group, click below.